Everpar Advisors LLC Sells 40 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Everpar Advisors LLC trimmed its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.9% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,350 shares of the medical equipment provider’s stock after selling 40 shares during the period. Everpar Advisors LLC’s holdings in Intuitive Surgical were worth $705,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of the stock. Goldstone Financial Group LLC increased its stake in Intuitive Surgical by 7.1% in the 4th quarter. Goldstone Financial Group LLC now owns 513 shares of the medical equipment provider’s stock worth $268,000 after acquiring an additional 34 shares during the last quarter. Decker Retirement Planning Inc. bought a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $36,000. Occidental Asset Management LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at $296,000. Empirical Asset Management LLC increased its position in Intuitive Surgical by 21.7% in the fourth quarter. Empirical Asset Management LLC now owns 19,393 shares of the medical equipment provider’s stock worth $10,122,000 after purchasing an additional 3,456 shares during the last quarter. Finally, Bouvel Investment Partners LLC raised its stake in Intuitive Surgical by 2.9% during the fourth quarter. Bouvel Investment Partners LLC now owns 14,356 shares of the medical equipment provider’s stock valued at $7,493,000 after purchasing an additional 406 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares of the company’s stock, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Brian Edward Miller sold 2,553 shares of Intuitive Surgical stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the transaction, the executive vice president now owns 7,066 shares in the company, valued at $3,638,990. This represents a 26.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 48,190 shares of company stock worth $25,012,927. 0.80% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Intuitive Surgical stock opened at $584.08 on Friday. The stock has a market cap of $208.04 billion, a price-to-earnings ratio of 93.90, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. The firm has a 50-day moving average of $538.34 and a two-hundred day moving average of $497.08. Intuitive Surgical, Inc. has a 1 year low of $355.17 and a 1 year high of $585.50.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Research analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on ISRG. Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Stifel Nicolaus lifted their price target on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. Robert W. Baird upped their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Finally, Royal Bank of Canada increased their price target on Intuitive Surgical from $525.00 to $555.00 and gave the company an “outperform” rating in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.